511 related articles for article (PubMed ID: 15752253)
1. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
2. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response.
Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X
Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of autoantibodies against a-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome.
Yavuz S; Toker E; Bicakcigil M; Mumcu G; Cakir S
J Rheumatol; 2006 Jul; 33(7):1289-92. PubMed ID: 16821267
[TBL] [Abstract][Full Text] [Related]
4. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
[TBL] [Abstract][Full Text] [Related]
5. Anti-SSA/Ro and anti-SSB/La antibodies in serum and saliva of patients with Sjogren's syndrome.
Ben-Chetrit E; Fischel R; Rubinow A
Clin Rheumatol; 1993 Dec; 12(4):471-4. PubMed ID: 8124907
[TBL] [Abstract][Full Text] [Related]
6. Adult heart block is associated with disease activity in primary Sjögren's syndrome.
Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR
Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186
[TBL] [Abstract][Full Text] [Related]
7. Salivary anti-spectrin autoantibodies in Sjögren's syndrome.
Moody M; Zipp M; Al-Hashimi I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):322-7. PubMed ID: 11250630
[TBL] [Abstract][Full Text] [Related]
8. Comparison of salivary calmodulin binding proteins in Sjögren's syndrome and healthy individuals.
Deming FP; Al-Hashimi I; Haghighat N; Hallmon WW; Kerns DG; Abraham C; Rivera-Hidalgo F
J Oral Pathol Med; 2007 Mar; 36(3):132-5. PubMed ID: 17305633
[TBL] [Abstract][Full Text] [Related]
9. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.
Hansen B; Manthorpe R
Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875
[TBL] [Abstract][Full Text] [Related]
11. Clinical and immunological characteristics of elderly onset Sjögren's syndrome: a comparison with younger onset disease.
Tishler M; Yaron I; Shirazi I; Yaron M
J Rheumatol; 2001 Apr; 28(4):795-7. PubMed ID: 11327252
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
[TBL] [Abstract][Full Text] [Related]
13. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
[TBL] [Abstract][Full Text] [Related]
14. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome.
Toker E; Yavuz S; Direskeneli H
Br J Ophthalmol; 2004 Mar; 88(3):384-7. PubMed ID: 14977774
[TBL] [Abstract][Full Text] [Related]
15. [Detection of anti-Ro(SS-A) by using immunoimprint. Comparison with double diffusion in agar. Apropos of a series of 63 primary Gougerot-Sjögren syndromes].
Meyer O; Haim T; Bourgeois P; Palazzo E; Ribard P; Belmatoug N; Kahn MF
Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):149-55. PubMed ID: 1905419
[TBL] [Abstract][Full Text] [Related]
16. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
17. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
Miyawaki S
Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
[TBL] [Abstract][Full Text] [Related]
18. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
Vissink A; Kalk WW; Mansour K; Spijkervet FK; Bootsma H; Roodenburg JL; Kallenberg CG; Nieuw Amerongen AV
Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome.
Locht H; Pelck R; Manthorpe R
J Rheumatol; 2008 May; 35(5):845-9. PubMed ID: 18381788
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
